title: AT1 receptor blockers for cognition decline after cardiac surgery?
authors.forename: Roxana
authors.initials: R
authors.lastname: Oprisiu-Fournier
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Serot
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Achard
authors.forename: Franz H
authors.initials: FH
authors.lastname: Messerli
authors.forename: Sandra E
authors.initials: SE
authors.lastname: Black
authors.forename: Albert
authors.initials: A
authors.lastname: Fournier
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D013504:Cardiovascular Surgical Procedures / Q000009:adverse effects*; D003071:Cognition / Q000187:drug effects / Q000502:physiology; D003072:Cognition Disorders / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D044140:Receptor, Angiotensin, Type 1 / Q000502:physiology
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D044140:Receptor, Angiotensin, Type 1